SELLAS Life Sciences Stock Jumps 13% on Executive Severance Changes, Sparking Buyout Speculation
According to a Securities and Exchange Commission filing disclosed on Tuesday, SELLAS Life Sciences Group, Inc. (SLS) shares jumped nearly 13% on Thursday after the biopharmaceutical company announced updates to severance arrangements for its top three executives. The changes, which took effect
SLS1.80%
GateNews·06-25 18:26
